Article
Novel Immune Check-Point Regulators in Tolerance Maintenance
18 Aug 2015
Abstract excerpt
The great success of anti-cytotoxic lymphocyte antigen 4 (CTLA4) and anti-programed cell death protein 1 (PD1) in cancer treatment has encouraged more effort in harnessing the immune response through immunomodulatory molecules in various diseases. The immunoglobulin (Ig) super family comprises the majority of immunomodulatory molecules. Discovery of novel Ig super family members has brought novel insights into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
